Medtronic wins FDA nod for new lengths of drug-coated balloon

Medtronic (NYSE:MDT) said today that it won FDA approval for 200mm and 250mm lengths of its In.Pact Admiral drug-coated balloon.

The newly-approved lengths are designed to treat patients with longer, more complex superficial femoral artery lesions, according to the medtech giant.

Get the full story at our sister site, Drug Delivery Business News.

The post Medtronic wins FDA nod for new lengths of drug-coated balloon appeared first on MassDevice.

from MassDevice https://ift.tt/2HQzAe6